• UAE’s pharma market on growth path SHEM OIRERE
    March 13, 2023
    The COVID-19 pandemic outbreak in early 2020 may have triggered additional growth of United Arab Emirates (UAE) pharmaceuticals market.
  • UAE’s Growing Pharmaceutical Market Shem Oirere
    February 22, 2022
    The United Arab Emirates (UAE) is one of the fastest-growing pharmaceutical markets in the Middle East, which, though depending on imports to meet the increasing demand for medical drugs...
  • UAE approves Sinopharm’s protein-based vaccine ExpressPharma
    December 29, 2021
    The United Arab Emirates (UAE) has approved emergency use of Sinopharm’s protein-based COVID-19 vaccine and it will be available to the public as a booster dose starting January 2022, the health ministry said.
  • UAE approves Sputnik Light vaccine as universal booster dose for Covid-19 Pharmaceutical-Technology
    December 02, 2021
    The Russian Direct Investment Fund (RDIF) has announced that the UAE Ministry of Health and Prevention (MOHAP) approved the one-shot Sputnik Light vaccine as a universal booster shot for all the vaccines used in the country for Covid-19.
  • UAE rolls out Sinopharm COVID-19 vaccine for children expresspharma
    August 04, 2021
    The Gulf Arab state, which has among the world's highest immunisation rates, was already providing the Pfizer-BioNTech vaccine for children aged 12-15.
  • UAE approves Moderna COVID-19 vaccine for emergency use firstwordpharma
    July 05, 2021
    The United Arab Emirates has approved Moderna’s COVID-19 vaccine for emergency use, the health ministry said in a statement on state news agency WAM on Sunday, as reported by Fidelity.
  • UAE approves Sputnik V Covid-19 vaccine for emergency use pharmaceutical-technology
    January 22, 2021
    The Russian Direct Investment Fund has announced that the UAE Ministry of Health and Prevention (MOHAP) authorised Sputnik V vaccine against Covid-19.
  • China’s Sinopharm begins late stage trial of COVID-19 vaccine in UAE expresspharma
    July 20, 2020
    The human trial is a partnership between Sinopharm’s China National Biotec Group (CNBG), Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42) and the Abu Dhabi Department of Health.
  • UAE conducts an innovative medical study biospectrumasia
    May 15, 2018
    The new procedure involves using a special coloured dye solution mixed into a sweet drink, which is then drunk by the child.
PharmaSources Customer Service